Pfizer and Allergan scrap $160 bln deal

ReutersNewsPublished: April 6, 20166 views
Published: April 6, 2016

U.S. drug maker Pfizer has agreed to terminate its $160 billion agreement to acquire Botox maker Allergan Plc, in a major victory to U.S. President Barack Obama's drive to stop tax-dodging corporate mergers. Hayley Platt reports

Be the first to suggest a tag